Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients

Gut

Volumn 58, Issue 2, 2009, Pages 220-227

  Epple, H J ^a   Schneider, T ^a   Troeger, H ^a   Kunkel, D ^a   Allers, K ^a   Moos, V ^a   Amasheh, M ^a   Loddenkemper, C ^a   Fromm, M ^a   Zeitz, M ^a   Schulzke, J D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CLAUDIN 1; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 4; MANNITOL; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITOMETRY; DUODENUM BIOPSY; FEMALE; GASTROINTESTINAL DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; INTESTINE CRYPT; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; JEJUNUM MUCOSA; MALE; MICROSCOPY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERODIAGNOSIS; SPECTROSCOPY; STAINING; TIGHT JUNCTION;

ADULT; ANIMALS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL MEMBRANE PERMEABILITY; CYTOKINES; DISEASE PROGRESSION; DUODENUM; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; FEMALE; HIV INFECTIONS; HUMANS; INTERLEUKIN-13; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; MANNITOL; MEMBRANE PROTEINS; MIDDLE AGED; RATS; RATS, WISTAR; TIGHT JUNCTIONS; VIRUS REPLICATION;

EID: 58949102533     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.150425     Document Type: Article

References (63)

1. Schneider T, Jahn HU, Schmidt W, et al. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut 1995;37:524-9.
2. Fackler OT, Schafer M, Schmidt W, et al. HIV-1 p24 but not proviral load is increased in the intestinal mucosa compared with the peripheral blood in HIV-infected patients. Aids 1998;12:139-46.
3. Brenchley JM, Schacker TW, Ruff LE, et al. C04+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004;200:749-59.
4. Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005;434:1093-7.
5. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003;77:11708-17.
6. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006:12:1365-71.
7. Brenchley JM, Price DA, Douek DC. HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006;7:235-9.
8. Derdeyn CA, Silvestri G. Viral and host factors in the pathogenesis of HIV infection. Curr Opin Immunol 2005;17:366-73.
9. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999;179:859-70.
10. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Ads 2003;17:1881-8.
11. . Lim SG, Menzies IS, Lee CA, et al. Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand J Gastroenterol 1993;28:573-80.
12. Keating J, Bjarnason I. Somasundaram S, et al. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 1995,37:623-9.
13. Bjarnason I, Sharpstone DR, Francis N, et al. Intestinal inflammation, ileal structure and function in HIV. Aids 1996;10:1385-91.
14. Stockmann M, Fromm M, Schmitz H, et al. Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion. Aids 1998;12:43-51.
15. Stockmann M, Schmitz H, Fromm M, et al. Mechanisms of epithelial barrier impairment in HIV infection. Ann NY Acad Sci 2000;915:293-303.
16. Greenson JK, Belitsos PC, Yardley JH, et al. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med 1991;114:366-72.
17. Ullrich R, Zeitz M, Heise W, et al. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med 1989;111:15-21.
18. Zeitz M, Ullrich R, Schneider T, et al. HIV/SIV enteropathy. Ann NY Acad Sci 1998;859:139-48.
19. Kotler DP, Gaetz HP, Lange M, et al. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421-8.
20. Ullrich R, Heise W, Bergs C, et al. Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus. Gastroenterology 1992:102:1483-92.
21. Batman PA, Kapembwa MS, Miller AR, et al. HIV enteropathy: comparative morphometry of the jejunal mucosa of HIV infected patients resident in the United Kingdom and Uganda. Gut 1998;43:350-5.
22. Schmitz H, Rokos K, Florian P, et al. Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells. Aids 2002;16:983-91.
23. Stockmann M, Gitter AH, Sorgenfrei D, et al. Low edge damage container insert that adjusts intestinal forceps biopsies into Ussing chamber systems. Pflugers Arch 1999;438:107-12.
24. Gitter AH, Fromm M, Schulzke JD. Impedance analysis for the determination of epithelial and subepithelial resistance in intestinal tissues. J Biochem Biophys Methods 1998;37:35-46.
25. Burgel N, Bojarski C, Mankertz J, et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002;123:433-43.
26. + secretion in human distal colon driven by prostaglandin E2. Am J Physiol 1996:271 :G669-74.
27. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001:120:411-22.
28. Schneider T, Zippel T, Schmidt W, et al. Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients. Gut 1998;42:357-61.
29. Tai YH, Tai CY. The conventional short-circuiting technique under-short-circuits most epithelia. J Membr Biol 1981;59:173-7.
30. Heller F, Florian P, Bojarski C, et al. lnterleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005;129:550-64.
31. Bode H, Schmidt W, Schulzke JD, et al. The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir but not indinavir impair the epithelial barrier in the human intestinal cell line HT-29/B6. Aids 1999;13:2595-7.
32. Kewenig S, Schneider T, Hohloch K, et al. Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 1999;116:1115-23.
33. Malebranche R, Arnoux E, Guerin JM, et al. Acquired immunodeficiency syndrome with severe gastrointestinal manifestations in Haiti. Lancet 1983;2:873-8.
34. Zeissig S, Bojarski C, Buergel N, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 2004;53:1295-302.
35. Bojarski C, Gitter AH, Bendfeldt K, et al. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol 2001;535:541-52.
36. Gitter AH, Bendfeldt K, Schulzke JD, et al. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J 2000;14:1749-53.
37. Chin AC, Vergnolle N, MacNaughton WK, et al. Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci USA 2003;100:11104-9.
38. Kiesslich R, Goetz M, Angus EM, et al. Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 2007;133:1769-78.
39. Watson AJ, Chu S, Sieck L, et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 2005;129:902-12.
40. Mullin JM, Agostino N, Rendon-Huerta E, et al. Keynote review: epithelial and endothelial barriers in human disease. Drug Discov Today 2005;10:395-408.
41. D'Atri F, Citi S. Molecular complexity of vertebrate tight junctions. Mol Membr Biol 2002;19:103-12.
42. Inai T, Kobayashi J, Shibata Y. Claudin-1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol 1999;78:849-55.
43. Furuse M, Hata M, Furuse K, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002;156:1099-111.
44. Amasheh S, Meiri N, Gitter AH, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002;115:4969-76.
45. Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999;147:891-903.
46. Fish SM, Proujansky R, Reenstra WW. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut 1999;45:191-8.
47. Adams RB, Planchon SM, Roche JK. IFN-gamma modulation of epithelial barrierb function. Time course, reversibility, and site of cytokine binding. J Immunol 1993;150:2356-63.
48. Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-7.
49. Schmitz H, Fromm M, Bentzel CJ, et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999;112:137-46.
50. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164-72.
51. Grotjohann I, Schmitz H, Fromm M, et al. Effect of TNF alpha and IFN gamma on epithelial barrier function in rat rectum in vitro. Ann NY Acad Sci 2000;915:282-6.
52. Schulbin H, Bode H, Stocker H, et al. Cytokine expression in the colonic mucosa of HIV-infected individuals before and during nine months of antiretroviral therapy. Antimicmb Agents Chemother 2008.
53. Reka S, Garro ML, Kotler DP. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection. Lymphokine Cytokine Res 1994;13:391-8.
54. Reka S, Kotler DP. Detection and localization of HIV RNA and TNF mRNA in rectal biopsies from patients with AIDS. Cytokine 1993;5:305-8.
55. McGowan I, Radford-Smith G, Jewell DP. Cytokine gene expression in HIV-infected intestinal mucosa. Aids 1994;8:1569-75.
56. McGowan I, Elliott J, Fuerst M, et al. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 2004;37:1228-36.
57. Steffen M, Reinecker HC, Petersen J, et al. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clin Exp Immunol 1993;91:30-6.
58. Snijders F, van Deventer SJ, Bartelsman JF, etal. Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal mucosa. Aids 1995;9:367-73.
59. Pender SL, Tickle SP, Docherty AJ, et al. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-90.
60. Poritz LS, Garver Kl, Tilberg AF, et al. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004;116:14-8.
61. Patrick DM, Leone AK, Shellenberger JJ, et al. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 2006;6:2.
62. Clark E, Hoare C, Tanianis-Hughes J, et al. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005;128:1258-67.
63. Clark EC, Patel SD, Chadwick PR, et al. Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate. Gut 2003;52:224-30.